Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Older adults
2022
2017
Clear all
Type of publications
Systematic reviews (SYSVAC)
(199)
Topics
Available to download in languages
Regions
Africa
(2)
Americas
(3)
Eastern Mediterranean
(1)
Europe
(1)
South-East Asia
(2)
Western Pacific
(3)
Countries
Diseases
COVID-19
(188)
Pneumococcal disease
(11)
Haemophilus influenzae type B
(1)
Hepatitis B
(1)
Herpes zoster
(3)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(5)
Influenza
(25)
Lyme disease, Borreliosis
(1)
Yellow fever
(2)
Vaccine topics
Acceptance
(15)
Administration
(30)
Coverage
(2)
Economic aspects
(3)
Efficacy/effectiveness
(71)
Ethical issues
(1)
Safety
(105)
Target population
Older adults
(199)
Adolescents
(106)
Adults
(257)
All age groups
(230)
Children
(50)
Healthcare workers
(75)
Newborn
(24)
Parents/caregivers
(18)
Pregnant women
(45)
Risk group
(1)
Travellers
(1)
Publication date
2022
(194)
2017
(5)
2024
(1)
2023
(64)
2021
(107)
2020
(58)
2019
(2)
2018
(3)
2016
(6)
2015
(3)
2014
(1)
2012
(3)
199 results found
2022
∙
Becerril-Gaitan, A. Vaca-Cartagena, B. F. Ferrigno, A. S. Mesa-Chavez, F. Barrientos-Gutierrez, T. Tagliamento, M. Lambertini, M. Villarreal-Garza, C.
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
2022
∙
Cheng, H. Peng, Z. Si, S. Alifu, X. Zhou, H. Chi, P. Zhuang, Y. Mo, M. Yu, Y.
Immunogenicity and Safety of Homologous and Heterologous Prime-Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
2022
∙
Mehrabi Nejad, M. M. Moosaie, F. Dehghanbanadaki, H. Haji Ghadery, A. Shabani, M. Tabary, M. Aryannejad, A. SeyedAlinaghi, S. Rezaei, N.
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
2022
∙
Luo, N. Chen, X. Du, J. Mei, B. Wang, A. Kuang, F. Fang, C. Gan, Y. Peng, F. Yang, X. Dahmen, U. Li, B. Song, S.
Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: a systematic review and meta-analysis
2022
∙
Cho, K. Park, S. Kim, E. Y. Koyanagi, A. Jacob, L. Yon, D. K. Lee, S. W. Kim, M. S. Radua, J. Elena, D. Il Shin, J. Smith, L.
Immunogenicity of COVID-19 Vaccines in Patients with Diverse Health Conditions: a Comprehensive Systematic Review
2022
∙
Tang, K. T. Hsu, B. C. Chen, D. Y.
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
2022
∙
Yang, B. Huang, X. Gao, H. Leung, N. H. Tsang, T. K. Cowling, B. J.
Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis
2022
∙
Kwon, C. Y. Lee, B.
Impact of COVID-19 Vaccination on Heart Rate Variability: A Systematic Review
2022
∙
Tang, K. Wei, Z. Wu, X.
Impaired serological response to COVID-19 vaccination following anti-cancer therapy: a systematic review and meta-analysis
2022
∙
Zheng, X. Gao, F. Wang, L. Meng, Y. Ageno, W. Qi, X.
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register